MRKR
Marker Therapeutics·NASDAQ
--
--(--)
--
--(--)
MRKR fundamentals
During Q4 2025, Marker Therapeutics (MRKR) reported revenue of 1.10M, a YoY change of -51.00%. Net income was -1.70M, a YoY change of 55.62%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2016 | Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | 183.06K -- | 0 -- | -- -- | 205.99K -- | 0 -100.00% | 0 -- | -- -- | 0 -100.00% | 0 -- | 213.19K -- | -- -- | 466.79K -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 1.24M -- | 964.32K -- | 790.51K -- | 999.57K -- | 759.14K -38.86% | 1.23M +28.00% | 762.66K -3.52% | 257.61K -74.23% | 1.06M +39.17% | 1.24M +0.79% | 1.17M +53.31% | 1.93M +647.66% | 2.25M +113.13% | 349.10K -71.94% | 861.18K -26.35% | 1.23M -35.99% | 1.10M -51.00% | 3.55M -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 183.06K -- | 0 -- | -- -- | 205.99K -- | 0 -100.00% | 0 -- | -- -- | 0 -100.00% | 0 -- | 0 -- | -- -- | 466.79K -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 1.24M -- | 964.32K -- | 790.51K -- | 999.57K -- | 759.14K -38.86% | 1.23M +28.00% | 762.66K -3.52% | 257.61K -74.23% | -2.25M -396.99% | -- -- | 1.17M +53.31% | 1.93M +647.66% | 2.25M +199.87% | -- -- | 861.18K -26.35% | 1.23M -35.99% | 1.10M -51.00% | -- -- |
Other Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 213.19K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 3.31M -- | 1.24M -- | -- -- | -- -- | -- -- | 349.10K -71.94% | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 183.06K -- | 0 -- | -- -- | 205.99K -- | 0 -100.00% | 0 -- | -- -- | 0 -100.00% | 0 -- | 0 -- | -- -- | 466.79K -- | -- -- | -466.79K -- | -- -- | -- -- | -- -- | -- -- | 964.32K -- | 790.51K -- | 999.57K -- | -2.75M -- | 1.23M +28.00% | 762.66K -3.52% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 1.75M +70.57% | 2.43M +113.14% | 2.72M +56.60% | 1.59M -29.42% | 2.42M +37.81% | 2.39M -1.33% | 4.17M +53.31% | 2.68M +68.44% | 3.20M +32.30% | 4.88M +103.90% | 4.43M +6.13% | 135.87M +4969.08% | 5.64M +76.34% | 5.87M +20.37% | 5.65M +27.69% | 5.58M -95.90% | 6.64M +17.83% | 6.82M +16.19% | 7.38M +30.44% | 8.51M +52.61% | 8.78M +32.17% | 10.91M +59.86% | 10.02M +35.89% | 11.01M +29.35% | 10.76M +22.53% | 6.06M -44.46% | 6.83M -31.90% | 3.80M -65.49% | 5.54M -48.47% | 4.90M -19.18% | 3.46M -49.35% | 3.99M +5.17% | 3.79M -31.58% | 3.48M -28.99% | 4.33M +25.11% | 6.11M +53.05% | 4.96M +30.71% | 5.12M +47.30% | 3.37M -22.10% | 2.99M -51.13% | 16.44M -- |
Selling, General and Administrative Expenses | 767.99K +83.38% | 1.18M +25.67% | 1.61M +109.60% | 1.13M -60.44% | 1.43M +85.91% | 1.19M +1.11% | 2.55M +58.11% | 1.24M +9.70% | 1.60M +11.92% | 3.05M +156.44% | 2.55M +0.07% | 17.18M +1280.26% | 2.81M +75.59% | 2.72M -10.87% | 2.54M -0.59% | 1.91M -88.86% | 2.83M +0.76% | 2.55M -6.39% | 2.57M +1.43% | 2.52M +31.92% | 3.14M +11.00% | 3.56M +39.72% | 3.24M +25.91% | 2.99M +18.36% | 3.73M +18.96% | 3.14M -11.91% | 3.23M -0.15% | 1.62M -45.94% | 2.17M -41.94% | 2.52M -19.66% | 1.41M -56.32% | 1.38M -14.76% | 1.22M -43.80% | 1.14M -54.66% | 854.68K -39.50% | 1.03M -25.42% | 1.37M +12.41% | 945.16K -17.23% | 1.02M +19.79% | 846.61K -17.56% | 4.18M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 9.98M -- | -- -- | -- -- | -- -- | 10.47M +4.96% | -- -- | -- -- | -- -- | 12.92M +23.42% | -- -- | -- -- | -- -- | 11.34M -12.29% | -- -- | -- -- | 1.41M -- | 1.38M -87.85% | 1.22M -- | 1.14M -- | 854.68K -39.50% | 1.03M -25.42% | 1.37M +12.41% | 945.16K -17.23% | 1.02M +19.79% | 846.61K -17.56% | 4.18M -- |
Research and Development Expenses | 985.75K +61.76% | 1.25M +520.49% | 1.11M +14.51% | 456.79K +174.49% | 989.09K +0.34% | 1.20M -3.64% | 1.62M +46.33% | 1.44M +214.34% | 1.60M +61.72% | 1.83M +51.89% | 1.88M +15.64% | 118.69M +8166.38% | 2.83M +77.09% | 3.15M +72.56% | 3.12M +66.12% | 3.66M -96.92% | 3.82M +34.73% | 4.28M +35.67% | 4.80M +54.03% | 5.98M +63.43% | 5.64M +47.85% | 7.35M +71.85% | 6.78M +41.24% | 8.02M +33.99% | 7.03M +24.51% | 2.92M -60.22% | 3.59M -47.06% | 2.18M -72.78% | 3.38M -51.94% | 2.38M -18.67% | 2.04M -43.07% | 2.62M +19.93% | 2.58M -23.74% | 2.34M -1.79% | 3.47M +69.74% | 5.09M +94.33% | 3.14M +21.76% | 4.18M +78.86% | 2.35M -32.42% | 2.14M -57.91% | 11.80M -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 453.13K -- | 0 -- | 0 -- | 0 -- | 453.13K -- |
Operating Income | -1.75M -70.57% | -2.43M -113.14% | -2.72M -56.60% | -1.59M +29.42% | -2.42M -37.81% | -2.39M +1.33% | -3.99M -46.58% | -2.68M -68.44% | -3.20M -32.30% | -4.67M -95.29% | -4.43M -11.00% | -135.87M -4969.08% | -5.64M -76.34% | -5.87M -25.67% | -5.65M -27.69% | -5.36M +96.05% | -6.64M -17.83% | -6.36M -8.24% | -7.38M -30.44% | -8.51M -58.68% | -8.78M -32.17% | -10.91M -71.59% | -10.02M -35.89% | -9.76M -14.76% | -9.79M -11.54% | -5.27M +51.71% | -5.83M +41.87% | -3.04M +68.88% | -4.31M +56.00% | -4.13M +21.53% | -3.20M +45.08% | -2.94M +3.32% | -2.55M +40.85% | -2.31M +44.17% | -2.40M +25.01% | -3.86M -31.44% | -4.61M -80.80% | -4.26M -84.61% | -2.14M +10.97% | -1.88M +51.21% | -12.89M -- |
Non-Operating Income (Loss) | -3.00M -1014.98% | 8.40M +114.22% | 618.67K -97.95% | 14.50K -97.59% | -3.00K +99.90% | 499.87K -94.05% | 4.00K -99.35% | -3.00K -120.69% | 1.00K +133.33% | -139.00K -127.81% | 40.00K +900.00% | 311.72K +10490.77% | 319.55K +31854.50% | 303.17K +318.11% | 195.25K +388.12% | 282.88K -9.25% | 157.97K -50.56% | 15.86K -94.77% | 4.67K -97.61% | 1.25K -99.56% | 1.54K -99.03% | 2.40K -84.85% | -2.41M -51648.85% | 969 -22.42% | -115.76K -7631.75% | 35.79K +1389.22% | 99.75K +104.15% | -4.68K -583.38% | 84.65K +173.13% | 35.08K -1.97% | 218.09K +118.63% | 201.34K +4398.44% | 156.19K +84.51% | 115.39K +228.93% | 91.68K -57.96% | 73.75K -63.37% | 162.49K +4.03% | 245.47K +112.73% | 138.06K +50.59% | 165.63K +124.59% | 711.65K -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 18.00K -- | -- -- | -- -- | -- -- | 31.00K +72.22% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | -3.00M -1014.98% | 8.40M +114.22% | 618.67K -97.95% | 14.50K -97.63% | -3.00K +99.90% | 499.87K -94.05% | 4.00K -99.35% | -3.00K -120.69% | 1.00K +133.33% | -139.00K -127.81% | 40.00K +900.00% | 58.00K +2033.33% | -9.00K -1000.00% | -7.00K +94.96% | -64.00K -260.00% | 80.00K +37.93% | 31.00K +444.44% | 0 +100.00% | 0 +100.00% | -31.00K -138.75% | -- -- | -- -- | -2.41M -- | 0 +100.00% | -118.88K -- | -- -- | -- -- | -114.09K -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | -- -- | 117.44K -- | 0 -- | 0 -- | -- -- |
Net Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | -253.72K -- | -328.55K -- | -310.17K -- | -259.25K -- | -184.88K +27.14% | -126.97K +61.35% | -15.86K +94.89% | -4.67K +98.20% | -1.25K +99.32% | -1.54K +98.79% | -2.40K +84.85% | -791 +83.05% | -969 +22.42% | -3.12K -102.80% | -35.79K -1389.22% | -99.75K -12510.62% | -109.41K -11191.02% | -84.65K -2615.88% | -35.08K +1.97% | -218.09K -118.63% | -201.34K -84.02% | -156.19K -84.51% | -115.39K -228.93% | -91.68K +57.96% | -73.75K +63.37% | -162.49K -4.03% | -128.03K -10.95% | -138.06K -50.59% | -165.63K -124.59% | -594.21K -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 253.72K -- | 328.55K -- | 310.17K -- | 259.25K -- | 184.88K -27.14% | 126.97K -61.35% | 15.86K -94.89% | 4.67K -98.20% | 1.25K -99.32% | 1.54K -98.79% | 2.40K -84.85% | 791 -83.05% | 969 -22.42% | 3.12K +102.80% | 35.79K +1389.22% | 99.75K +12510.62% | 109.41K +11191.02% | 84.65K +2615.88% | 35.08K -1.97% | 218.09K +118.63% | 201.34K +84.02% | 156.19K +84.51% | 115.39K +228.93% | 91.68K -57.96% | 73.75K -63.37% | 162.49K +4.03% | 128.03K +10.95% | 138.06K +50.59% | 165.63K +124.59% | 594.21K -- |
Pretax Income From Continuing Operations | -4.75M -577.83% | 5.97M +109.92% | -2.10M -107.38% | -1.58M +4.59% | -2.42M +49.05% | -1.89M -131.69% | -3.99M -89.52% | -2.68M -70.18% | -3.20M -32.09% | -4.81M -154.19% | -4.39M -10.11% | -135.56M -4951.80% | -5.32M -66.40% | -5.57M -15.74% | -5.46M -24.41% | -5.08M +96.25% | -6.49M -21.94% | -6.34M -13.85% | -7.37M -35.02% | -8.51M -67.49% | -8.78M -35.37% | -10.91M -71.99% | -12.43M -68.61% | -9.76M -14.76% | -9.91M -12.88% | -5.23M +52.02% | -5.73M +53.93% | -3.04M +68.83% | -4.22M +57.37% | -4.10M +21.67% | -2.98M +47.93% | -2.74M +10.08% | -2.39M +43.36% | -2.19M +46.51% | -2.31M +22.59% | -3.79M -38.42% | -4.45M -85.81% | -4.02M -83.14% | -2.00M +13.41% | -1.72M +54.63% | -12.18M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 3.67K -- | -- -- | -- -- | -- -- | 49.95K +1259.27% | -- -- | -- -- | -- -- | -15.16K -130.34% | -- -- |
Income from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -4.01M -- | -1.19M -- | -813.06K -- | -742.75K -- | 6.61M +264.90% | 0 +100.00% | -62.94K +92.26% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -4.75M -577.83% | 5.97M +109.92% | -2.10M -107.38% | -1.58M +4.59% | -2.42M +49.05% | -1.89M -131.69% | -3.99M -89.52% | -2.68M -70.18% | -3.20M -32.09% | -4.81M -154.19% | -4.39M -10.11% | -135.56M -4951.80% | -5.32M -66.40% | -5.57M -15.74% | -5.46M -24.41% | -5.08M +96.25% | -6.49M -21.94% | -6.34M -13.85% | -7.37M -35.02% | -8.51M -67.49% | -8.78M -35.37% | -10.91M -71.99% | -12.43M -68.61% | -9.76M -14.76% | -9.91M -12.88% | -9.24M +15.24% | -6.92M +44.33% | -3.86M +60.50% | -4.97M +49.88% | 2.52M +127.21% | -2.98M +56.91% | -2.80M +27.31% | -2.39M +51.83% | -2.19M -187.16% | -2.31M +22.59% | -3.84M -36.91% | -4.45M -85.81% | -4.02M -83.14% | -2.00M +13.41% | -1.70M +55.62% | -12.16M -- |
Net Income Attributable to Owners of the Company | -4.75M -577.83% | 5.97M +109.92% | -2.10M -107.38% | -1.58M +4.59% | -2.42M +49.05% | -1.89M -131.69% | -3.99M -89.52% | -2.68M -70.18% | -3.20M -32.09% | -4.81M -154.19% | -4.39M -10.11% | -135.56M -4951.80% | -5.32M -66.40% | -5.57M -15.74% | -5.46M -24.41% | -5.08M +96.25% | -6.49M -21.94% | -6.34M -13.85% | -7.37M -35.02% | -8.51M -67.49% | -8.78M -35.37% | -10.91M -71.99% | -12.43M -68.61% | -9.76M -14.76% | -9.91M -12.88% | -9.24M +15.24% | -6.92M +44.33% | -3.86M +60.50% | -4.97M +49.88% | 2.52M +127.21% | -2.98M +56.91% | -2.80M +27.31% | -2.39M +51.83% | -2.19M -187.16% | -2.31M +22.59% | -3.84M -36.91% | -4.45M -85.81% | -4.02M -83.14% | -2.00M +13.41% | -1.70M +55.62% | -12.16M -- |
Net Income Attributable to Common Stockholders | -4.75M -577.83% | 5.97M +109.92% | -2.10M -107.38% | -1.58M +4.59% | -2.42M +49.05% | -1.89M -131.69% | -3.99M -89.52% | -2.68M -70.18% | -3.20M -32.09% | -4.81M -154.19% | -4.39M -10.11% | -135.56M -4951.80% | -5.32M -66.40% | -5.57M -15.74% | -5.46M -24.41% | -5.08M +96.25% | -6.49M -21.94% | -6.34M -13.85% | -7.37M -35.02% | -8.51M -67.49% | -8.78M -35.37% | -10.91M -71.99% | -12.43M -68.61% | -9.76M -14.76% | -9.91M -12.88% | -9.24M +15.24% | -6.92M +44.33% | -3.86M +60.50% | -4.97M +49.88% | 2.52M +127.21% | -2.98M +56.91% | -2.80M +27.31% | -2.39M +51.83% | -2.19M -187.16% | -2.31M +22.59% | -3.84M -36.91% | -4.45M -85.81% | -4.02M -83.14% | -2.00M +13.41% | -1.70M +55.62% | -12.16M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -2.42M -- | -1.89M -- | -3.99M -- | -2.68M -- | -3.20M -32.09% | -4.81M -154.19% | -4.39M -10.11% | -135.56M -4951.80% | -5.32M -66.40% | -5.57M -15.74% | -5.46M -24.41% | -5.08M +96.25% | -6.49M -21.94% | -6.34M -13.85% | -7.37M -35.02% | -8.51M -67.49% | -8.78M -35.37% | -10.91M -71.99% | -12.43M -68.61% | -9.76M -14.76% | -9.91M -12.88% | -9.24M +15.24% | -6.92M +44.33% | -3.86M +60.50% | -4.97M +49.88% | 2.52M +127.21% | -2.98M +56.91% | -2.80M +27.31% | -2.39M +51.83% | -2.19M -187.16% | -- -- | -- -- | -4.45M -85.81% | -4.02M -83.14% | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | -- -- | -- -- | -2.42M -- | -1.89M -- | -3.99M -- | -2.68M -- | -3.20M -32.09% | -4.81M -154.19% | -4.39M -10.11% | -135.56M -4951.80% | -5.32M -66.40% | -5.57M -15.74% | -5.46M -24.41% | 16.35M +112.06% | -6.49M -21.94% | -6.34M -13.85% | -7.37M -35.02% | 20.20M +23.55% | -8.78M -35.37% | -10.91M -71.99% | -12.43M -68.61% | 32.12M +59.00% | -9.91M -12.88% | -9.24M +15.24% | -6.92M +44.33% | 26.07M -18.81% | -4.97M +49.88% | 2.52M +127.21% | -- -- | -- -- | -- -- | -2.19M -187.16% | -- -- | -- -- | -- -- | -4.02M -83.14% | -- -- | -- -- | -- -- |
Basic EPS | -0.81 -2600.00% | 1.01 +156.11% | -0.29 -104.12% | -- -- | -0.29 +64.20% | -0.22 -121.78% | -0.39 -34.48% | -0.25 -- | -0.3 -3.45% | -0.41 -86.36% | -0.32 +17.95% | -2.98 -1092.00% | -0.12 +60.00% | -0.12 +70.73% | -0.12 +62.50% | -0.11 +96.31% | -0.14 -16.67% | -0.14 -16.67% | -0.16 -33.33% | -0.17 -54.55% | -0.16 -14.29% | -0.13 +7.14% | -0.15 +6.25% | -0.12 +29.41% | -1.19 -643.75% | -1.11 -753.85% | -0.83 -453.33% | -0.05 +58.33% | -0.57 +52.10% | 0.29 +126.13% | -0.34 +59.04% | -0.32 -540.00% | -0.27 +52.63% | -0.25 -186.21% | -0.26 +23.53% | -0.36 -12.50% | -0.4 -48.15% | -0.29 -16.00% | -0.12 +53.85% | -0.1 +72.22% | -0.91 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.63 -- | -0.69 -- | -- -- | -0.48 -- | -0.47 +25.40% | -0.34 +50.72% | -- -- | -0.27 +43.75% | -0.25 +46.81% | -0.26 +23.53% | -- -- | -0.4 -48.15% | -0.29 -16.00% | -0.12 +53.85% | -- -- | -- -- |
Basic EPS from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.48 -- | -0.14 -- | -- -- | -0.09 -- | 0.75 +256.25% | 0 +100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Diluted EPS | -0.81 -2600.00% | 0.35 +119.44% | -0.29 -106.86% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.41 -- | -0.32 -- | -- -- | -0.12 -- | -0.12 +70.73% | -0.12 +62.50% | -- -- | -0.14 -16.67% | -0.14 -16.67% | -0.16 -33.33% | -- -- | -0.16 -14.29% | -0.13 +7.14% | -0.15 +6.25% | -- -- | -1.19 -643.75% | -1.11 -753.85% | -0.83 -453.33% | -- -- | -0.57 +52.10% | 0.29 +126.13% | -0.34 +59.04% | -- -- | -0.27 +52.63% | -0.25 -186.21% | -0.26 +23.53% | -- -- | -0.4 -48.15% | -0.29 -16.00% | -0.12 +53.85% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.63 -- | -0.69 -- | -- -- | -0.48 -- | -0.47 +25.40% | -0.34 +50.72% | -- -- | -0.27 +43.75% | -0.25 +46.81% | -0.26 +23.53% | -- -- | -0.4 -48.15% | -0.29 -16.00% | -0.12 +53.85% | -- -- | -- -- |
Diluted EPS from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.48 -- | -0.14 -- | -- -- | -0.09 -- | 0.75 +256.25% | 0 +100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
You can ask Aime
What is the revenue and EPS growth rate for Marker Therapeutics year over year?What does Marker Therapeutics do and what are its main business segments?What is the market's earnings forecast for Marker Therapeutics next quarter?What is Marker Therapeutics's latest dividend and current dividend yield?Did Marker Therapeutics beat or miss consensus estimates last quarter?What is Marker Therapeutics's gross profit margin?What were the key takeaways from Marker Therapeutics’s earnings call?What guidance did Marker Therapeutics's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
